MedPath

A multi-institutional prospective randomized controlled study investigating the outcome and safety of the lymphadenectomy plus radical nephroureterectomy for upper tract urothelial cancer

Not Applicable
Recruiting
Conditions
pper tract urothelial carcinoma
Registration Number
JPRN-UMIN000020506
Lead Sponsor
Department of Urology, Akita University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
204
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who meet the criteria below will be excluded: 1.Are presenting with cTa or cTis tumor. 2.Are presenting with an upper tract urothelial carcinomas located in the ureter distal to the lower renal pole level. 3.Are presenting with cN1 or cN2 disease and lymphadenectomy is strongly recommended. 4.Are presenting with distant metastases. 5.Have histories bladder cancer or have simultaneous bladder cancer.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath